Literature DB >> 6640900

The "HemoQuant" test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials.

S Schwartz, J Dahl, M Ellefson, D Ahlquist.   

Abstract

We describe a new, specific, quantitative method for fecal blood, based on conversion of nonfluorescing heme to fluorescing porphyrins, that obviates serious deficiencies inherent in currently used tests. A two-reagent system is used to determine the two hemoglobin-related fractions that are found in feces. The hot citric acid extract includes only the variable fraction of porphyrins that have been preformed from heme in the intestinal tract; this often is the major fraction. Total hemoglobin is indirectly determined by reaction with heated oxalic acid:FeSO4 reagent, which converts the remaining heme to porphyrin without loss of the preformed porphyrins. A three-step purification procedure eliminates interfering materials. Analytical recovery of added hemoglobin is linearly related to concentration over a several-thousand-fold range. The assay is equally applicable to whole blood or to sub-microgram amounts of hemoglobin in the 8-mg (wet weight) fecal sample tested. Quality control by liquid chromatographic and fluorometric analysis documents fluorescence specificity of the heme-derived porphyrins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6640900

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Quantitative measurement of faecal blood loss: comparison of radioisotopic and chemical analyses.

Authors:  M B Leahy; M J Pippard; M B Salzmann; M G Rinsler; R Hesp; T Smith
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

2.  Effects of high-fiber diet on fecal blood content (HemoQuant assay) in healthy subjects.

Authors:  J L Slavin; E A Melcher; M Sundeen; S Schwartz
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  [A new latex agglutination test for the immunologic detection of occult blood in stool].

Authors:  P Herzog; U König; K H Holtermüller
Journal:  Klin Wochenschr       Date:  1989-03-01

4.  Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.

Authors:  A M Joseph; T W Crowson; E C Rich
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

Review 5.  Cows' milk induced intestinal bleeding in infancy.

Authors:  P B Sullivan
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

6.  Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading.

Authors:  A Ferguson; K A Humphreys; N M Croft
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

7.  Faecal blood loss in response to exercise.

Authors:  J D Robertson; R J Maughan; R J Davidson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

8.  Experimental detection of canine haemoglobin (occult blood) in canine faeces by reversed passive latex agglutination.

Authors:  T Jinbo; R Shinmura; T Shida; M Shimizu; M Honda; S Hayashi; K Iguchi; S Yamamoto
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

Review 9.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

10.  Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.

Authors:  Charles Frost; Sunil Nepal; Jessie Wang; Alan Schuster; Wonkyung Byon; Rebecca A Boyd; Zhigang Yu; Andrew Shenker; Yu Chen Barrett; Rogelio Mosqueda-Garcia; Frank Lacreta
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.